4//SEC Filing
Smith Julie 4
Accession 0001209191-21-043338
CIK 0001623526other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:02 PM ET
Size
5.4 KB
Accession
0001209191-21-043338
Insider Transaction Report
Form 4
Smith Julie
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-06-08+11,650→ 11,650 totalExercise: $40.37Exp: 2031-06-07→ Common Stock (11,650 underlying)
Footnotes (1)
- [F1]The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001557928
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:02 PM ET
- Size
- 5.4 KB